Minerva IPO Presentation Deck

Minerva Surgical Revenue Growth Revenue ($mm) 50 40 30 20 10 0 2016A ■ Minerva sales = IUH sales 38.5% CAGR 2017A 2018A 2019A 2020A 1H 2021A Quarterly Revenue ($mm) 20 15 10 5 0 Q1 il Q4 Q2 Q3 2019A Note: 2020A includes product sales from IUH acquisition (Genesys HTA, Symphion, Resectr) starting in May 2020 and full year sales for Minerva ES Preliminary financial results: Q3'21 revenue: $12.4-$12.6mm Q3'21 YTD revenue: $38.4- $38.6mm Q1 Q2 Q3 Q4 Q1 Q2 2020A 2021A 35

View entire presentation